Company History

  • April 2016

    China Biologic increased its equity interest in Guizhou Taibang to 85.27% through a series of capital injections.
  • February 2016

    Huitian received the GMP certification from the CFDA for its new plasma production facility in Xi’an.
  • October 2015

    China Biologic increased its equity interest in Guizhou Taibang to 81.81% through a series of capital injections.
  • October 2015

    Shandong Taibang’s newly built branch plasma collection facility in the Shanting District of Zaozhuang City, which is operated under Ningyang plasma collection station, obtained its operating permit and commenced operation.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:2 [1] [2] [3] [4] [5] [6] [7] [8] [9] 
© 2018 China Biologic Products Holdings, Inc. All Rights Reserved.